Remote Exercise for Learning Anger and Excitation Management
RELAX
1 other identifier
interventional
58
1 country
1
Brief Summary
The immediate objective of this project was to demonstrate the feasibility of Remote Exercises for Learning Anger and Excitation Management (RELAX). The application is a remote, technology- enabled, anger treatment and management system based on current evidence-based CBT interventions. The project's objective was to show that RELAX (1) enables the practice of anger management strategies remotely through mobile phone interfaces; (2) integrates with evidence-based treatments through the implementation of an existing CBT anger management course; (3) provides information, direction, and feedback through physiological sensors and signal analysis; and (4) supports communication and direction by the therapist through a web-based therapist interface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 5, 2014
CompletedFirst Posted
Study publicly available on registry
May 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedNovember 6, 2017
November 1, 2016
1.8 years
May 5, 2014
October 31, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dimensions of Anger Reactions (DAR-5)
The DAR-5 is a reliable and valid screening measure of common anger reactions. Its brevity is useful for rapidly assessing the presence of anger problems in different populations. The strength of the DAR-5 is that it employs a minimum number of items to measure the anger construct. Item content pertains to anger frequency, intensity, duration, interpersonal aggressiveness, and the extent to which anger interferes with interpersonal relationships.
up to 3 month follow-up
Secondary Outcomes (1)
State-Trait Anger Expression Inventory-2 (STAXI-2)
Immediate post treatment and 3 month follow-up
Other Outcomes (1)
PTSD Checklist (PCL-5)
Immediate post treatment and 3 month follow-up
Study Arms (2)
Anger Management Therapy
ACTIVE COMPARATORAnger Management Therapy (AMT) is a 12-session manual-driven cognitive-behavioral intervention found efficacious for anger management treatment.
Anger Management Therapy & RELAX app
EXPERIMENTALAnger Management Therapy (AMT) is a 12-session manual-driven cognitive-behavioral intervention found efficacious for anger management treatment. RELAX app (1) enables the practice of anger management strategies remotely through mobile phone interfaces; (2) integrates with evidence-based treatments through implementing an existing CBT anger management course; (3) provides information, direction, and feedback through physiological sensors; and (4) supports communication and direction by the therapist through a web-based therapist interface and a remote and secure patient data server.
Interventions
Anger Management Therapy (AMT) is a 12-session manual-driven cognitive-behavioral intervention found efficacious for anger management treatment.
Anger Management Therapy (AMT) is a 12-session manual-driven cognitive-behavioral intervention found efficacious for anger management treatment. RELAX app (1) enables the practice of anger management strategies remotely through mobile phone interfaces; (2) integrates with evidence-based treatments through implementing an existing CBT anger management course; (3) provides information, direction, and feedback through physiological sensors; and (4) supports communication and direction by the therapist through a web-based therapist interface and a remote and secure patient data server.
Eligibility Criteria
You may qualify if:
- a score of 20 or higher on the 10-item Trait Scale of the STAXI
- participants taking psychoactive medications have to have a stable regimen for at least 45 days prior to study entry
- participants must be able to read, understand, and sign the consents themselves and be willing and able to comply with all study related procedures
You may not qualify if:
- active psychotic symptoms/disorder as determined by the Structured Clinical Interview (SCID) for Diagnostic and Statistical Manual of Mental Disorders(DSM)
- active homicidal or suicidal ideation as determined by the SCID
- any significant cognitive impairment or history of Organic Mental Disorder as determined by the SCID
- active (current) substance dependence as determined by the SCID (lifetime substance dependence or substance abuse not excluded)
- unwillingness to refrain from substance abuse during treatment
- female Veterans
- vulnerable persons such as those described in the section Ethical Considerations and Regulatory Issues, Vulnerable Population
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Pacific Islands Health Care Systemlead
- United States Department of Defensecollaborator
- Charles River Analyticscollaborator
Study Sites (1)
VA Pacific Islands Healthcare System
Honolulu, Hawaii, 96819, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret-Anne Mackintosh, Ph.D.
VA Pacific Islands Healthcare System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2014
First Posted
May 7, 2014
Study Start
March 1, 2014
Primary Completion
December 1, 2015
Study Completion
May 1, 2016
Last Updated
November 6, 2017
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share